Evidence map›Paper›PMID 35888345›Full record

ArticleMaterials (Basel, Switzerland)2022

The Structure and Function of Biomaterial Endolysin EFm1 from

Xuerong Zhou, Xiaotao Zeng, Li Wang, Yanhui Zheng, Guixiang Zhang, Wei Cheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuerong ZhouState Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.
Xiaotao ZengDivision of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, China.
Li WangState Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.
Yanhui ZhengDivision of Respiratory and Critical Care Medicine, Respiratory Infection and Intervention Laboratory of Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, China.
Guixiang ZhangLaboratory of Bariatric and Metabolic Surgery, Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, No. 37, Chengdu 610041, China.ORCID 0000-0003-2371-1027
Wei ChengState Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.

Funding

1.3.5 Project for Disciplines Excellence of West China Hospital, Sichuan University ZYYC20005National Natural Science Foundation of China 31870836 and 32071236
6 · The paper itself

Abstract

The endolysin EFm1 from the

Indexed as

CRISPR interferencecrystal structureE. faecalisendolysin EFm1lytic activity

Identifiers

PMID35888345
PMCPMC9316690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.